Cargando…

Qili Qiangxin (QLQX) capsule as a multi-functional traditional Chinese medicine in treating chronic heart failure (CHF): A review of ingredients, molecular, cellular, and pharmacological mechanisms

Chronic heart failure (CHF) is a key part of cardiovascular continuum. Under the guidance of the theory of vessel-collateral doctrine, the present study proposes therapeutic benefits of Qili Qiangxin (QLQX) capsules, an innovative Chinese medicine, on chronic heart failure. The studies show that mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tongxing, Hou, Bin, Qin, Haoran, Liang, Junqing, Shi, Min, Song, Yanfei, Ma, Kun, Chen, Meng, Li, Huixin, Ding, Guoyuan, Yao, Bing, Wang, Zhixin, Wei, Cong, Jia, Zhenhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682643/ https://www.ncbi.nlm.nih.gov/pubmed/38034785 http://dx.doi.org/10.1016/j.heliyon.2023.e21950

Ejemplares similares

Clinical Effect of Qili Qiangxin Capsule Combined with Sacubitril-Valsartan in Patients with Chronic Heart Failure
por: Yao, Jiafang, et al.
Publicado: (2022)

Potential mechanisms of Qili Qiangxin capsule to prevent pulmonary arterial hypertension based on network pharmacology analysis in a rat model
por: Han, Xiao, et al.
Publicado: (2022)

Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis
por: Xiang, Qian, et al.
Publicado: (2022)

Qili Qiangxin capsules for chronic heart failure: A GRADE-assessed clinical evidence and preclinical mechanism
por: Xing, Xiaoxiao, et al.
Publicado: (2023)

Retracted: Clinical Effect of Qili Qiangxin Capsule Combined with Sacubitril-Valsartan in Patients with Chronic Heart Failure
por: Healthcare Engineering, Journal of
Publicado: (2023)

Traditional Chinese medicine Qili qiangxin inhibits cardiomyocyte apoptosis in rats following myocardial infarction
por: XIAO, JUN, et al.
Publicado: (2015)

Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure
por: Cui, Xiangning, et al.
Publicado: (2015)

Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials
por: Wei, Jingjing, et al.
Publicado: (2022)

Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation
por: Wang, Tongxing, et al.
Publicado: (2023)

Clinical Efficacy of Qili Qiangxin Capsule Combined with Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis
por: Xu, Xiaoming, et al.
Publicado: (2021)

Beneficial Effects of Qili Qiangxin Capsule on Lung Structural Remodeling in Ischemic Heart Failure via TGF-β1/Smad3 Pathway
por: He, Yaoyao, et al.
Publicado: (2015)

Clinical effects of a standardized Chinese herbal remedy, Qili Qiangxin, as an adjuvant treatment in heart failure: systematic review and meta-analysis
por: Sun, Jin, et al.
Publicado: (2016)

Antidepressant Active Ingredients From Chinese Traditional Herb Panax Notoginseng: A Pharmacological Mechanism Review
por: Li, Yanwei, et al.
Publicado: (2022)

Long-term toxicological studies on the Chinese medicine 2036 Specialty-Qiangxin recipe in rats
por: Zhao, Andong, et al.
Publicado: (2021)

Network pharmacology and molecular docking study on the active ingredients of qidengmingmu capsule for the treatment of diabetic retinopathy
por: Zhang, Mingxu, et al.
Publicado: (2021)

Identification of the active ingredients and pharmacological effects of Kuntai capsules in the treatment of primary ovarian insufficiency: A review
por: Liu, Feng-Xia, et al.
Publicado: (2023)

Synthesis of CHF(2)-substituted 3-azabicyclo[3.1.0]hexanes by photochemical decomposition of CHF(2)-pyrazolines
por: Zheng, Yang, et al.
Publicado: (2018)

Identify the Key Active Ingredients and Pharmacological Mechanisms of Compound XiongShao Capsule in Treating Diabetic Peripheral Neuropathy by Network Pharmacology Approach
por: Yu, Meixiang, et al.
Publicado: (2019)

Author Correction: Network pharmacology and molecular docking study on the active ingredients of qidengmingmu capsule for the treatment of diabetic retinopathy
por: Zhang, Mingxu, et al.
Publicado: (2021)

Reading Level and Suitability of Congestive Heart Failure (CHF) Education in a Mobile App (CHF Info App): Descriptive Design Study
por: Athilingam, Ponrathi, et al.
Publicado: (2019)

A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19
por: Zhang, Xiaobo, et al.
Publicado: (2021)

Exploring the active ingredients and mechanism of Shenzhi Tongxin capsule against microvascular angina based on network pharmacology and molecular docking
por: Xuan, Xiaoyu, et al.
Publicado: (2023)

Integrating network pharmacology and experimental verification strategies to reveal the active ingredients and molecular mechanism of Tenghuang Jiangu Capsule against osteoporosis
por: Li, Miao, et al.
Publicado: (2023)

Nanoemulsion‐Loaded Capsules for Controlled Delivery of Lipophilic Active Ingredients
por: Chen, Liang‐Hsun, et al.
Publicado: (2020)

Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats
por: Hong, Li-li, et al.
Publicado: (2022)

Measuring dobutamine (Db) clearance during continuous hemofiltration (CHF)
por: Van der Linden, T, et al.
Publicado: (1998)

Electrocardiographic and other Noninvasive Hemodynamic Markers in Decompensated CHF Patients
por: Piccirillo, Gianfranco, et al.
Publicado: (2023)

Developing a core outcome set on traditional Chinese medicine (COS-TCM) for chronic heart failure (CHF): a study protocol
por: Zhang, Mingyan, et al.
Publicado: (2021)

Exploring the Mechanism of Action Compound-Xueshuantong Capsule in Diabetic Retinopathy Treatment Based on Network Pharmacology
por: Li, Haoran, et al.
Publicado: (2020)

Telemedicine Facilitates CHF Home Health Care for Those with Systolic Dysfunction
por: Seibert, Pennie S., et al.
Publicado: (2008)

CRT-D Therapy in Patients with Decompensated NYHA Class-Four CHF
por: Zaeem, Faisal, et al.
Publicado: (2012)

CERN’s light guide sells for 8000 CHF for a good cause
Publicado: (2009)

Acute Effects of Continuous Positive Airway Pressure on Pulse Pressure in CHF
por: Blanco, Jacobo Bacariza, et al.
Publicado: (2015)

Serum Uric Acid level in the severity of Congestive Heart Failure (CHF)
por: khan, Adnan, et al.
Publicado: (2017)

Investigation of the Active Ingredients and Mechanism of Hudi Enteric-Coated Capsules in DSS-Induced Ulcerative Colitis Mice Based on Network Pharmacology and Experimental Verification
por: Ding, Panghua, et al.
Publicado: (2021)

Network Pharmacology-Based Prediction of Active Ingredients and Mechanisms of Lamiophlomis rotata (Benth.) Kudo Against Rheumatoid Arthritis
por: Jiang, Yunbin, et al.
Publicado: (2019)

Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects
por: Huang, Dan, et al.
Publicado: (2021)

Corrigendum: Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects
por: Huang, Dan, et al.
Publicado: (2021)

Antifungal and Immunomodulatory Ingredients from Traditional Chinese Medicine
por: Zhong, Hua, et al.
Publicado: (2022)

Effects of Shenfu Qiangxin Drink on H(2)O(2)-induced oxidative stress, inflammation and apoptosis in neonatal rat cardiomyocytes and possible underlying mechanisms
por: Zhang, Sujie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9ct438o5bl5r404f1n0qkbpchm